Blue Water Acquisition IV

This submission transitions BWIV from a shell seeking a target into active negotiations, providing investors a concrete reference valuation ($490 million) and a ninety-day execution window ahead of the 2027 deadline. Per the press release, the acquisition combines Venezuelan energy exposure—described by the U.S. Department of Energy as possessing the world's largest proven oil reserves in the Orinoco Belt—and regulated under structures potentially utilizing OFAC General License 52—with a fintech platform leveraging artificial intelligence and machine learning risk analytics to expand credit access for underserved SMEs in Latin America and Canada. Joseph Hernandez states the combined company will separate its fintech operations into a standalone publicly traded entity within thirty to ninety days post-closing to unlock distinct valuations. Because the transaction remains contingent upon satisfactory due diligence, definitive agreement negotiation, board and shareholder approvals, and regulatory clearance, the filing signals sponsor momentum while preserving execution uncertainty. Investors will require the forthcoming Form S-4 and proxy statement/prospectus to evaluate definitive pricing, lock-up arrangements, sponsor promote mechanics, and precise redemption trigger dates.

The independent registered public accounting firm’s report explicitly includes a section on 'Substantial Doubt about the Company’s Ability to Continue as a Going Concern,' noting that management acknowledges insufficient financial resources to sustain operations for one year and expects to continue incurring significant costs pursuing acquisition plans. Per Note 1, the Company has not selected any specific Business Combination target and has not engaged in substantive discussions with any target. The financial statements record 6,500,000 public warrants and 212,500 private placement warrants outstanding, each exercisable for one Class A ordinary share at $11.50 per share, with exercise permitted only after the later of 12 months from the IPO close or 30 days post-combination. The auditor also flagged that the Company relies on the Sponsor to settle pre-IPO expenses and fund ongoing liquidity needs, underscoring that all operational and deal-progression metrics remain entirely dependent on future sponsor commitments and target identification rather than historical performance or existing pipeline disclosures.

This filing establishes the trust value, the deadline for a business combination, and the terms of sponsor and insider commitments. It provides the baseline for tracking redemption rights, lock-ups, and sponsor conduct. The IPO size and trust are significant for evaluating potential deal sizes. The 21-month deadline is standard; any extension would require shareholder approval. The filing also details the founder share forfeiture mechanism and the underwriter's deferred compensation.

The prospectus defines all key mechanics for investors: the trust value is $10.00 per share; the redemption deadline is 21 months from closing (approximately December 2027); extensions require shareholder approval and offer redemption rights; sponsor paid a nominal price for founder shares creating significant dilution risk and potential conflicts; non-managing sponsor investors have a large potential stake and could influence approval without other public votes; the company has no target and no operations; management has prior SPAC experience including the now-bankrupt Clarus Therapeutics deal and the Blue Water III SPAC; the offering is not subject to Rule 419 protections; and the company may be classified as a PFIC for U.S. tax purposes.

Investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct can record this update as confirmed zero movement in insider positioning. The document contains no further substance: it discloses no customer relationships, revenue figures, market size data, strategic initiatives, technology developments, partnership agreements, litigation exposures, or personnel changes. No numerical figures appear in the text, so no calculations, rounding, or assumed trust conventions apply. For a SPAC with the tracked 2027-12-23 deadline, a clean Form 3 simply verifies that no insider activity requires recalibration of timing models or redemption assumptions.

This filing moves the SPAC toward effectiveness of its IPO. It provides investors with the final prospectus containing all material terms: trust per share at $10.00, 21-month deadline to complete a business combination, redemption rights for public shareholders, sponsor compensation (founder shares at $0.005, private placement units at $10.00), and detailed dilution analysis. The filing also discloses a material weakness in internal controls and substantial doubt about the company's ability to continue as a going concern, which are important risk factors for investors. The inclusion of executed agreements confirms the offering structure and underwriter compensation.

This S-1/A provides the first detailed look at the Company’s financial condition, including a working capital deficiency of $181,480 as of December 31, 2025, and a going concern opinion. It identifies a material weakness in internal controls. The trust mechanics are standard for a SPAC, but the involvement of non-managing sponsor investors with indirect stakes in founder shares creates potential alignment-of-interest issues. The management team’s prior SPAC experience includes Blue Water Acquisition Corp. III, which completed its IPO in June 2025 but whose management resigned in November 2025, and Blue Water Acquisition Corp. (Blue Water I), which completed a business combination with Clarus Therapeutics in September 2021; Clarus later filed for Chapter 11 bankruptcy in September 2022. The filing discloses that the Company may pursue targets previously discussed by Blue Water III’s management. The dilution table shows that at maximum redemption, net tangible book value per share could be negative ($0.83 without over-allotment, $0.85 with). The redemption deadline is 24 months from the closing of this offering, with potential extensions subject to shareholder approval but no limit on number of extensions; however, the Company says it does not expect to extend beyond 36 months.

This filing sets forth all key terms for the SPAC IPO: 12,500,000 units at $10.00 per unit ($125 million gross proceeds), each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. The trust will hold $125 million ($10.00 per share). The company has 24 months from closing to complete a business combination. The sponsor purchased founder shares at $0.005 per share, creating significant dilution. The filing also describes the sponsor's compensation, private placement units, and the non-managing sponsor investors' interest. The independent auditor's report includes a going concern explanatory paragraph. The S-1 includes a detailed risk factor section and disclosure of a material weakness in internal controls. This is a new SPAC entry into the market.

What changed: Schedule 13G Joint Acquisition Statement (Exhibit 99.1). This exhibit formalizes a joint reporting agreement among Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross, confirming they will file subsequent beneficial ownership amendments collectively. As explicitly stated in the document, the undersigned acknowledge and agree to coordinate all future Schedule 13G filings and share responsibility for the completeness and accuracy of the information they submit, while remaining independently liable for one another's data only to the extent they know or suspect inaccuracies. The text discloses no share counts, percentage positions, voting directives, or corporate operations, and therefore reports no adjustments to redemption windows, trust conditions, merger execution, or sponsor governance. Why it matters: The filing maps institutional disclosure compliance rather than capital movement or transaction leverage. By contractually binding these parties to synchronized reporting, it clarifies accountability for aggregate position tracking but provides no visibility into stake size, potential redemption behavior, or extension dynamics. Investors monitoring BWIVs announced deal will find this administratively relevant for compliance tracking, yet substantively neutral regarding valuation, timing, or cash flow implications surrounding the trust account or acquisition target.

What changed: A joint filing agreement attached to a Schedule 13G beneficial ownership report, executed pursuant to Rule 13d-1(k) of the Securities Exchange Act of 1934. The filing text formally establishes that Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman agreed to file a joint regulatory disclosure concerning their beneficial ownership in Blue Water Acquisition Corp. IV as of March 31, 2026. Executed by attorney-in-fact Hayley Stein on May 13, 2026, the excerpt contains absolutely no data or commentary regarding the SPAC’s per-share trust value, shareholder redemption windows, deadline extensions, target acquisition status, or sponsor conduct. Why it matters: As a purely procedural compliance exhibit, this document does not shift the December 23, 2027 redemption horizon, modify the trust account balance, advance or stall merger negotiations, or reflect changes in sponsor behavior or capital commitments. Investors monitoring BWIV should look to the numerical portion of the companion Schedule 13G for actual share quantities, percentage thresholds, and whether any affiliated entity crossed the 5% cumulative reporting line that would trigger additional disclosure timing or potential activist posture. The excerpt contains no strategic, financial, operational, or customer-related claims attributable to management, advisors, or counterparties, meaning no new facts are introduced into the public record beyond the reaffirmation of joint reporting coordination among the listed Magnetar affiliates.

What changed: A Form 8-K current report accompanied by Exhibit 99.1, a press release announcing the administrative separation and independent trading of the company's initial public offering units. Blue Water Acquisition Corp. IV announced that commencing on or about May 11, 2026, unit holders may elect to split their positions into underlying securities. Each unit contains one Class A ordinary share and one-half of one redeemable warrant. Separated shares will trade under symbol BWIV and warrants under BWIV.WS, with remaining units continuing as BWIV.U. The filing specifies that no fractional warrants will be issued and brokers must contact Continental Stock Transfer & Trust Company to effect the separation. Chief Executive Officer Joseph Hernandez signed the 8-K, and contact information lists Stephanie Mercier. The attached press release states a registration statement on Form S-1 (333-291959) was declared effective on March 19, 2026. Why it matters: Unit separation alters the tradability and liquidity mechanics of the SPAC's capital structure ahead of the December 23, 2027 merger deadline. Allowing independent trading of equity (BWIV) and warrants (BWIV.WS) may shift secondary market volume, influence pre-merger price discovery, and affect shareholder decisions regarding redemption versus holding for a potential business combination. The press release outlines the sponsor's strategic focus on pursuing acquisitions among high-growth companies in the biotechnology, healthcare, and technology sectors, though no target, valuation, or deal timing is disclosed. Trust account mechanics and extension protocols remain unchanged by this administrative listing update.

What changed: Form 8-K Current Report filed as a Rule 425 written communication containing an Exhibit 99.1 press release announcing a letter of intent to acquire substantially all subsidiaries of Maha Capital AB. The filing advances the proposed transaction to the letter of intent stage without amending the per-share trust amount or the December 23, 2027 redemption deadline. Deal mechanics outline an approximately ninety-day window to negotiate definitive agreements, establish a five-member board with balanced representation between BWIV and Maha, and place temporary executive control with Chief Executive Officer Joseph Hernandez serving as Chairman and Interim Chief Executive Officer of the combined company. No sponsor departures, trust deposits, extension requests, or redemption term changes are reported. Why it matters: Per the press release furnished solely by Maha and independently unverified by BWIV, the transaction carries a reference valuation of approximately $490 million, derived from a 14-day volume-weighted average share price of SEK 12.84 and 351,991,889 outstanding shares as of April 27, 2026. The combined platform’s strategy centers on Venezuelan energy-related assets potentially operating under U.S. Department of the Treasury’s Office of Foreign Assets Control General License 52 authorizations, plus an AI-driven B2B credit and payments platform targeting underserved small and medium-sized enterprises in Latin America and Canada where traditional lending infrastructure is constrained. The filing notes strategic partnerships enhancing distribution within the global payments ecosystem and discloses that management plans to separate the fintech operations into a standalone publicly traded entity within approximately thirty to ninety days after closing. All claims regarding resource scale, production declines cited to the U.S. Department of Energy, technology capabilities, and future performance projections are labeled as forward-looking statements subject to due diligence, board/shareholder approvals, regulatory clearance, and geopolitical risks, with BWIV explicitly disclaiming any obligation to update information outside statutory requirements.

What changed: Current Report on Form 8-K (Regulation FD Disclosure) accompanying a press release (Exhibit 99.1) announcing a letter of intent to acquire substantially all subsidiaries of Maha Capital AB. The filing advances deal progress through an initial letter of intent without altering the existing trust account mechanics or the December 23, 2027 liquidation deadline. According to the attached press release, the parties intend to negotiate a definitive agreement and pursue closing within approximately ninety days following the April 28, 2026 announcement. Management establishes a reference equity market capitalization of approximately $490 million, calculated from a 14-day volume-weighted average share price of SEK 12.84 and 351,991,889 outstanding shares as of April 27, 2026. Governance expectations call for a five-member board with balanced representation, with Joseph Hernandez transitioning from BWIV Chairman and CEO to Chairman and Interim Chief Executive Officer of the combined entity. Shareholder redemption rights and trust distribution parameters remain unmodified by this submission. Why it matters: This submission transitions BWIV from a shell seeking a target into active negotiations, providing investors a concrete reference valuation ($490 million) and a ninety-day execution window ahead of the 2027 deadline. Per the press release, the acquisition combines Venezuelan energy exposure—described by the U.S. Department of Energy as possessing the world's largest proven oil reserves in the Orinoco Belt—and regulated under structures potentially utilizing OFAC General License 52—with a fintech platform leveraging artificial intelligence and machine learning risk analytics to expand credit access for underserved SMEs in Latin America and Canada. Joseph Hernandez states the combined company will separate its fintech operations into a standalone publicly traded entity within thirty to ninety days post-closing to unlock distinct valuations. Because the transaction remains contingent upon satisfactory due diligence, definitive agreement negotiation, board and shareholder approvals, and regulatory clearance, the filing signals sponsor momentum while preserving execution uncertainty. Investors will require the forthcoming Form S-4 and proxy statement/prospectus to evaluate definitive pricing, lock-up arrangements, sponsor promote mechanics, and precise redemption trigger dates.

What changed: A Joint Filing Agreement executed pursuant to Rule 13d-1(k) accompanying a Schedule 13G beneficial ownership statement, signed by Blue Water Acquisition IV LLC and Joseph Hernandez, Managing Member. The exhibit contains no adjustments to the redemption calendar, trust account balance, business combination deadline, extension voting mechanics, merger pipeline status, or sponsor conduct. It functions solely as an administrative protocol confirming that the named holders will file combined periodic ownership reports under the Exchange Act and assigns each party independent responsibility for the accuracy and completeness of their own disclosed data. Why it matters: For investors tracking BWIV’s pathway to closing or shareholder exit windows, this filing is procedurally neutral: it does not accelerate, delay, or conditionally alter any contractual timeline governing the ordinary shares. Because the document discloses no share counts, ownership percentages, or target-company metrics, it introduces no new dilution, pricing, or liquidity variables. The text makes no representations concerning customers, revenue streams, addressable market size, operational strategy, proprietary technology, strategic partnerships, pending litigation, or executive transitions; consequently, there are no external claims to attribute. The only quantifiable term present is the stated par value of $0.0001 per share. While material SPAC developments remain absent, the joint filing confirms continued governance alignment between the corporate entity and its managing member, signaling that standard regulatory housekeeping persists as the organization approaches its stated 2027-12-23 business combination horizon. Investors should monitor subsequent amended 13Gs, proxy solicitations, or Form 8-Ks for substantive trigger events.

What changed: Schedule 13G (beneficial ownership report). The filing discloses that Wealthspring Capital LLC and Matthew Simpson hold beneficial ownership interests in BWIV common stock that cross the statutory reporting threshold. The excerpt provides no share quantities, acquisition dates, purchase prices, or stated objectives. Consequently, there is no evidence of any shift in the trust asset allocation, the 2027-12-23 merger deadline, extension mechanisms, merger consideration, or sponsor conduct. No new contractual terms, voting pacts, or lock-up modifications are cited. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this Schedule 13G operates as a routine transparency filing rather than a mechanical trigger. Blockholder disclosures of this type do not extend deadlines, alter trust distribution calculations, force sponsor forfeitures, or guarantee merger approval. Without accompanying language declaring voting intent, board nomination plans, or explicit transaction support, the report neither advances nor threatens deal progress. Because the document contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, it offers no fundamental reassessment basis. Investors should watch for subsequent Schedules 13D, amended 13Gs, or definitive merger proxies to determine whether these holders intend to vote for or against the business combination.

What changed: SEC Form 8-K current report detailing the consummation of its initial public offering and simultaneous private placement, accompanied by audited financial statements and related notes. Per Item 8.01 and the audited balance sheet dated March 23, 2026, the Company closed its IPO on March 23, 2026, selling 13,000,000 units generating $130,000,000 in gross proceeds, which included a partial exercise of the over-allotment option for 500,000 units. Simultaneously, the Sponsor and BTIG purchased 425,000 private units for $4,250,000. The filing states exactly $130,000,000 of net proceeds were deposited into the trust account. The 21-month Completion Window to consummate an initial Business Combination begins immediately; the notes state that if the Company fails to complete a combination within that window, it must redeem public shares within ten business days thereafter. Transaction costs totaled $7,665,168, comprising $2,600,000 in cash underwriting fees, $4,550,000 in deferred underwriting fees payable to BTIG solely upon business combination completion, and $515,168 in other offering costs. The Sponsor waived redemption and liquidation rights for founder and private placement shares if the deadline passes, retained a liability obligation to restore the trust account if third-party claims reduce it below the lesser of $10.00 per public share or the actual balance minus taxes, pledged availability of non-interest bearing working capital loans up to $1,500,000, and committed to paying $10,000 monthly to a sponsor affiliate for administrative services. Why it matters: The independent registered public accounting firm’s report explicitly includes a section on 'Substantial Doubt about the Company’s Ability to Continue as a Going Concern,' noting that management acknowledges insufficient financial resources to sustain operations for one year and expects to continue incurring significant costs pursuing acquisition plans. Per Note 1, the Company has not selected any specific Business Combination target and has not engaged in substantive discussions with any target. The financial statements record 6,500,000 public warrants and 212,500 private placement warrants outstanding, each exercisable for one Class A ordinary share at $11.50 per share, with exercise permitted only after the later of 12 months from the IPO close or 30 days post-combination. The auditor also flagged that the Company relies on the Sponsor to settle pre-IPO expenses and fund ongoing liquidity needs, underscoring that all operational and deal-progression metrics remain entirely dependent on future sponsor commitments and target identification rather than historical performance or existing pipeline disclosures.

What changed: Form 8-K reporting the closing of the company's initial public offering (IPO) and the execution of related agreements. The company completed its IPO, raising $130 million in gross proceeds, which were deposited into a trust account. The company also sold private placement units to the sponsor and underwriter for $4.25 million. The company adopted its amended and restated memorandum and articles of association, appointed directors, and entered into various agreements (underwriting, warrant, trust, registration rights, private placement, indemnity, administrative services). The trust account holds $130 million, and the deadline for a business combination is 21 months from the IPO closing date (December 23, 2027). Why it matters: This filing establishes the trust value, the deadline for a business combination, and the terms of sponsor and insider commitments. It provides the baseline for tracking redemption rights, lock-ups, and sponsor conduct. The IPO size and trust are significant for evaluating potential deal sizes. The 21-month deadline is standard; any extension would require shareholder approval. The filing also details the founder share forfeiture mechanism and the underwriter's deferred compensation.

What changed: FORM 4 — insider ownership report. This document is a FORM 4 — insider ownership report. Bearing on SPAC mechanics, the filing discloses that Blue Water Acquisition IV LLC, identified as a 10% owner, executed an open-market purchase of 275,000 shares on 2026-03-23, bringing total post-transaction holdings to 275,000 shares. The report makes no alterations to the tracked redemption deadline of 2027-12-23, leaves the trust share framework untouched, and reflects zero movement in the announced deal timeline or sponsor commitments. Regarding other substantive claims, the document contains no data on customer contracts, revenue projections, market sizing, strategic roadmap, proprietary technology, partnership agreements, active litigation, or executive personnel changes; it exclusively logs this equity acquisition. Why it matters: Open-market purchases by a stated 10% owner directly contract the publicly tradable float and may modestly reduce redemption pressure ahead of the 2027-12-23 deadline, though a retained holding of 275,000 shares carries insufficient weight to independently secure financing conditions or force a de-SPAC close. Because the filing supplies no operational validation, target financials, or leadership transitions, it does not materially alter the fundamental calculus of the pending business combination beyond refreshing affiliate position tracking.